Pacific Biosciences Announces New Chief Executive Officer
Christian O. Henry Named Chief Executive Officer John F. Milligan, Ph.D. Named Chairman of the Board Ben Gong Named Interim CFO MENLO PARK, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) —…
Press releases
Pacific Biosciences of California, Inc. Announces Second Quarter 2020 Financial Results
MENLO PARK, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020. Total revenue…
Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry
Joint Research Effort Will Lead to Molecular Assays That Can Improve Variant Detection and Access Difficult-to-Sequence Regions of the Human Genome AUSTIN, Texas and MENLO PARK, Calif., Aug. 03, 2020…
Pacific Biosciences of California, Inc. Second Quarter 2020 Financial Results Call
MENLO PARK, Calif., July 24, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Second Quarter 2020 Financial Results…
Pacific Biosciences Announces Planned Retirement of CEO, Dr. Michael Hunkapiller
Dr. Hunkapiller to retire by the end of 2020 Susan K. Barnes, CFO to retire in August 2020 MENLO PARK, Calif., June 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of…
Pacific Biosciences of California, Inc. Announces Rescheduling of 2020 Annual Meeting of Stockholders and Move to Virtual Meeting
MENLO PARK, Calif., June 08, 2020 (GLOBE NEWSWIRE) — The Board of Directors of Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”) has announced that it is rescheduling the…
Pacific Biosciences of California, Inc. Announces First Quarter 2020 Financial Results
MENLO PARK, Calif., May 06, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2020. As previously…
Pacific Biosciences of California, Inc. First Quarter 2020 Financial Results Call
MENLO PARK, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its First Quarter 2020 Financial Results…
Inqaba Biotec Acquires The First PacBio Sequel II System In Africa
Deployment Expands Access to PacBio’s Highly Accurate Long Reads on the African Continent for a Variety of Applications, From Ethnic-Specific Reference Genomes to COVID-19 Research MENLO PARK, Calif. and PRETORIA,…
Pacific Biosciences Powers SARS-CoV-2 Research At Commercial, Academic And Government Labs
LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related…
Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore Technologies
MENLO PARK, Calif., March 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury…
Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors
MENLO PARK, Calif., March 05, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that industry…
Pacific Biosciences to Support Sequencing of California Species for the Earth BioGenome Project
Company Will Sponsor Sequencing and Assembly at UC Davis to Produce Reference-Grade Genomes for Several Ecologically Important Organisms in the State of California MENLO PARK, Calif. and DAVIS, Calif., Feb….
Pacific Biosciences Announces Retirement of Michael Phillips, SVP of Research and Development
Dr. Denis Zaccarin Succeeds Phillips to Lead Research and Development MENLO PARK, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality…
Pacific Biosciences Announces Fourth Quarter and Annual 2019 Financial Results
Annual Revenue Increase of 16% Year Over Year MENLO PARK, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its…
Search
Clear filters